• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁硫氨酸亚砜亚胺单独使用以及与美法仑(左旋苯丙氨酸氮芥,L-PAM)联合使用时,对人神经母细胞瘤细胞系具有高度细胞毒性。

Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines.

作者信息

Anderson C P, Tsai J, Chan W, Park C K, Tian L, Lui R M, Forman H J, Reynolds C P

机构信息

Division of Hematology-Oncology, Childrens Hospital Los Angles, California 90027, USA.

出版信息

Eur J Cancer. 1997 Oct;33(12):2016-9. doi: 10.1016/s0959-8049(97)00203-7.

DOI:10.1016/s0959-8049(97)00203-7
PMID:9516845
Abstract

Buthionine sulphoximine (BSO) selectively inhibits glutathione (GSH) synthesis and may enhance the antineuroblastoma activity of melphalan (L-PAM). We determined the cytotoxicity of BSO (dose range 0-1000 microM) alone and in combination with L-PAM (dose range 0-0 microM) in a panel of 18 human neuroblastoma cell lines. BSO alone was highly cytotoxic with 16/18 neuroblastoma cell lines having IC90 values (range 2.1- > 1000 microM) below the clinically achievable steady-state plasma level of 500 microM BSO. Maximal cell killing correlated with GSH levels decreased to less than 10% baseline, and was partially reversed by the addition of exogenous anti-oxidants (GSH, vitamin E and ascorbate). Fluorocytometric analysis of DNA fragments by the Tunnel method detected 92% of a BSO sensitive cell line in apoptosis after a 48 h exposure to 500 microM BSO. The combination of L-PAM and BSO synergistically enhanced the cell killing of L-PAM alone by > 1-3 logs (combination index < 1). We conclude that BSO has significant single-agent cytotoxicity against neuroblastoma and enhances cell killing when combined with L-PAM.

摘要

丁硫氨酸亚砜亚胺(BSO)可选择性抑制谷胱甘肽(GSH)的合成,并可能增强美法仑(L-PAM)抗神经母细胞瘤的活性。我们测定了单独使用BSO(剂量范围为0 - 1000微摩尔)以及与L-PAM联合使用(剂量范围为0 - 0微摩尔)时,对18种人神经母细胞瘤细胞系的细胞毒性。单独使用BSO具有高度细胞毒性,18种神经母细胞瘤细胞系中有16种的IC90值(范围为2.1 - >1000微摩尔)低于临床可达到的500微摩尔BSO稳态血浆水平。最大细胞杀伤与GSH水平降至低于基线的10%相关,并且通过添加外源性抗氧化剂(GSH、维生素E和抗坏血酸)可部分逆转。通过Tunnel法对DNA片段进行荧光细胞仪分析检测到,在暴露于500微摩尔BSO 48小时后,92%的对BSO敏感的细胞系发生凋亡。L-PAM与BSO联合使用可协同增强单独使用L-PAM时的细胞杀伤作用,增强幅度>1 - 3个对数(联合指数<1)。我们得出结论,BSO对神经母细胞瘤具有显著的单药细胞毒性,与L-PAM联合使用时可增强细胞杀伤作用。

相似文献

1
Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines.丁硫氨酸亚砜亚胺单独使用以及与美法仑(左旋苯丙氨酸氮芥,L-PAM)联合使用时,对人神经母细胞瘤细胞系具有高度细胞毒性。
Eur J Cancer. 1997 Oct;33(12):2016-9. doi: 10.1016/s0959-8049(97)00203-7.
2
Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.丁硫氨酸亚砜胺(BSO)与大剂量美法仑(L-PAM)对清髓性治疗后复发时建立的神经母细胞瘤细胞系的协同细胞毒性作用。
Bone Marrow Transplant. 2002 Aug;30(3):135-40. doi: 10.1038/sj.bmt.1703605.
3
Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line.丁硫氨酸亚砜亚胺和美法仑的清髓浓度可克服美法仑耐药神经母细胞瘤细胞系的耐药性。
J Pediatr Hematol Oncol. 2001 Nov;23(8):500-5. doi: 10.1097/00043426-200111000-00007.
4
Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis.丁硫氨酸亚砜胺消耗谷胱甘肽会通过凋亡对人神经母细胞瘤细胞系产生细胞毒性。
Exp Cell Res. 1999 Jan 10;246(1):183-92. doi: 10.1006/excr.1998.4303.
5
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma.谷胱甘肽合成抑制剂丁硫氨酸亚砜胺可协同增强美法仑对多发性骨髓瘤临床前模型的活性。
Blood Cancer J. 2014 Jul 18;4(7):e229. doi: 10.1038/bcj.2014.45.
6
Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression.丁硫氨酸亚砜胺与美法仑对疾病进展后衍生的神经母细胞瘤细胞系的协同作用。
Med Pediatr Oncol. 2000 Dec;35(6):659-62. doi: 10.1002/1096-911x(20001201)35:6<659::aid-mpo38>3.0.co;2-4.
7
Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.生物还原剂替拉扎明可逆转缺氧对丁硫氨酸亚砜亚胺对人神经母细胞瘤细胞系细胞毒性的拮抗作用。
Cancer Res. 2003 Apr 1;63(7):1520-6.
8
Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (L-phenylalanine mustard) in human colorectal cancer cells.谷胱甘肽耗竭对美法仑(L-苯丙氨酸氮芥)抑制人结肠癌细胞周期进程及诱导凋亡的影响。
Biochem Pharmacol. 1999 Aug 15;58(4):655-64. doi: 10.1016/s0006-2952(99)00130-6.
9
Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.硫醇调节剂丁硫氨酸亚砜胺对左旋苯丙氨酸氮芥的化学增敏作用。
Cancer Res. 1987 Mar 15;47(6):1593-7.
10
Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids.4HPR-BSO 联合治疗在神经母细胞瘤单层和球体中的有前景的效果。
Free Radic Biol Med. 2011 Sep 15;51(6):1213-20. doi: 10.1016/j.freeradbiomed.2011.06.019. Epub 2011 Jun 23.

引用本文的文献

1
KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia.KLF5通过控制谷胱甘肽代谢来抑制p190-BCR-ABL+ B细胞淋巴细胞白血病。
Oncotarget. 2018 Jul 3;9(51):29665-29679. doi: 10.18632/oncotarget.25667.
2
HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation.癌症进展中的血红素加氧酶-1诱导:细胞适应问题
Antioxidants (Basel). 2017 May 5;6(2):29. doi: 10.3390/antiox6020029.
3
Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.
谷胱甘肽介导的抗氧化反应与有氧代谢:决定高危神经母细胞瘤多药耐药性的两个关键因素。
Oncotarget. 2016 Oct 25;7(43):70715-70737. doi: 10.18632/oncotarget.12209.
4
Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine.硝呋替莫对神经肿瘤细胞有效且与丁硫氨酸亚砜胺具有协同作用。
Sci Rep. 2016 Jun 10;6:27458. doi: 10.1038/srep27458.
5
Combined Gene Expression and RNAi Screening to Identify Alkylation Damage Survival Pathways from Fly to Human.联合基因表达与RNA干扰筛选以鉴定从果蝇到人类的烷基化损伤存活途径。
PLoS One. 2016 Apr 21;11(4):e0153970. doi: 10.1371/journal.pone.0153970. eCollection 2016.
6
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.一项关于丁硫氨酸亚砜胺与美法仑联合自体干细胞治疗复发性/难治性高危神经母细胞瘤的I期神经母细胞瘤治疗新方法研究。
Pediatr Blood Cancer. 2016 Aug;63(8):1349-56. doi: 10.1002/pbc.25994. Epub 2016 Apr 19.
7
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma.谷胱甘肽合成抑制剂丁硫氨酸亚砜胺可协同增强美法仑对多发性骨髓瘤临床前模型的活性。
Blood Cancer J. 2014 Jul 18;4(7):e229. doi: 10.1038/bcj.2014.45.
8
Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.通过利用耐药性的适应性代价来靶向多药耐药癌症的致命弱点。
Chem Rev. 2014 Jun 11;114(11):5753-74. doi: 10.1021/cr4006236. Epub 2014 Apr 23.
9
Absence of MGST1 mRNA and protein expression in human neuroblastoma cell lines and primary tissue.人神经母细胞瘤细胞系和原代组织中 MGST1 mRNA 和蛋白表达缺失。
Free Radic Biol Med. 2014 Apr;69:167-71. doi: 10.1016/j.freeradbiomed.2014.01.021. Epub 2014 Jan 29.
10
Glutathione: overview of its protective roles, measurement, and biosynthesis.谷胱甘肽:其保护作用、测量方法及生物合成的概述
Mol Aspects Med. 2009 Feb-Apr;30(1-2):1-12. doi: 10.1016/j.mam.2008.08.006. Epub 2008 Aug 30.